ArticleCancer immunology, immunotherapy : CII2026
Stoking an anti-liver cancer immune response with cryoablation plus an intratumoral TLR9 agonist and dual checkpoint inhibitors.
Yunpeng Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.